Sep 12, 2017 12:30 pm UTC| Business
NEW YORK and BOSTON, Sept. 12, 2017 -- Mizuho Americas will host a Biotechnology Conference on September 19th at the Langham Hotel in Boston. The event will feature opportunities for institutional investors to meet...
Mitel Appoints Don Schleicher as SVP of America Sales
Sep 12, 2017 12:30 pm UTC| Business
OTTAWA, Sept. 12, 2017 -- Mitel® (Nasdaq:MITL) (TSX:MNW), a global leader in enterprise communications, announced today the appointment of Don Schleicher to head up the organization’s sales in the Americas region. Based...
Coupa is a “Great Place to Work”
Sep 12, 2017 12:30 pm UTC| Business
SAN MATEO, Calif., Sept. 12, 2017 -- Coupa Software (NASDAQ:COUP), a leader in cloud-based spend management, announced today that the company has been certified as a “Great Place to Work” by the Great Place to Work®...
Sep 12, 2017 12:30 pm UTC| Business
NORCROSS, Ga., Sept. 12, 2017 -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that the Company has received a Decision to Grant from...
EXL Healthcare achieves NCQA accreditation in Utilization Management
Sep 12, 2017 12:30 pm UTC| Business
NEW YORK, Sept. 12, 2017 -- EXL (NASDAQ:EXLS), a leading Operations Management and Analytics company, today announced that its wholly-owned subsidiary primarily responsible for the operations of its Healthcare business...
IXYS Introduces New 2.8kV, 3115A Fast Thyristor with Improved Power Rating
Sep 12, 2017 12:30 pm UTC| Business
LEIDEN, The Netherlands and CHIPPENHAM, United Kingdom, Sept. 12, 2017 -- IXYS Corporation (NASDAQ:IXYS), an international power and IC semiconductor company, today announced the launch of a new distributed gate...
Evoke Pharma Completes Dosing for Gimoti™ Comparative Exposure Pharmacokinetic Study
Sep 12, 2017 12:30 pm UTC| Business
SOLANA BEACH, Calif., Sept. 12, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has completed subject dosing...